Complement Component C5/C5a Antibodies

2037-C5) induces N-acetyl-beta -D-glucosaminidase release in the the dibutyryl cyclic-AMP differentiated U937 human histiocytic lymphoma cell line in a dose-dependent manner (orange line). N-Acetyl-beta -D-Glucosamin-idase Release elicited by Recombinant Human Complement Component C5a (10 ng/mL) is neutralized (green line) by increasing concen-trations of Mouse Anti-Human Complement Component C5a Monoclonal Antibody (Catalog # MAB2037). The ND₅₀ is typically 0.04-0.12 µg/mL in the presence of cytochalasin-B." class="big_lightbox"> 2037-C5) induces N-acetyl-beta -D-glucosaminidase release in the the dibutyryl cyclic-AMP differentiated U937 human histiocytic lymphoma cell line in a dose-dependent manner (orange line). N-Acetyl-beta -D-Glucosamin-idase Release elicited by Recombinant Human Complement Component C5a (10 ng/mL) is neutralized (green line) by increasing concen-trations of Mouse Anti-Human Complement Component C5a Monoclonal Antibody (Catalog # MAB2037). The ND₅₀ is typically 0.04-0.12 µg/mL in the presence of cytochalasin-B." alt="Recombinant Human Complement Component C5a (Catalog # 2037-C5) induces N-acetyl-beta -D-glucosaminidase release in the the dibutyryl cyclic-AMP differentiated U937 human histiocytic lymphoma cell line in a dose-dependent manner (orange line). N-Acetyl-beta -D-Glucosamin-idase Release elicited by Recombinant Human Complement Component C5a (10 ng/mL) is neutralized (green line) by increasing concen-trations of Mouse Anti-Human Complement Component C5a Monoclonal Antibody (Catalog # MAB2037). The ND₅₀ is typically 0.04-0.12 µg/mL in the presence of cytochalasin-B." class="big_thumb" />

2037-C5) was serially diluted and captured by Mouse Anti-Human Complement Component C5/C5a Monoclonal Antibody (Catalog # MAB2037) coated on a Clear Polystyrene Microplate (Catalog # DY990). Mouse Anti-Human Complement Component C5/C5a Monoclonal Antibody (Catalog # MAB20371) was biotinylated and incubated with the protein captured on the plate. Detection of the standard curve was achieved by incubating Streptavidin-HRP (Catalog # DY998)" class="big_lightbox"> 2037-C5) was serially diluted and captured by Mouse Anti-Human Complement Component C5/C5a Monoclonal Antibody (Catalog # MAB2037) coated on a Clear Polystyrene Microplate (Catalog # DY990). Mouse Anti-Human Complement Component C5/C5a Monoclonal Antibody (Catalog # MAB20371) was biotinylated and incubated with the protein captured on the plate. Detection of the standard curve was achieved by incubating Streptavidin-HRP (Catalog # DY998)" class="big_thumb" />

2037-C5) induces N-acetyl- beta -D-glucosaminidase release in the the dibutyryl cyclic-AMP differentiated U937 human histiocytic lymphoma cell line in a dose-dependent manner (orange line). N-Acetyl-beta -D-Glucosamin-idase Release elicited by Recombinant Human Complement Component C5a (15 ng/mL) is neutralized (green line) by increasing concen-trations of Goat Anti-Human Complement Component C5a Antigen Affinity-purified Polyclonal Antibody (Catalog # AF2037). The ND₅₀ is typically 0.15-0.75 µg/mL in the presence of cytochalasin-B." class="big_lightbox"> 2037-C5) induces N-acetyl- beta -D-glucosaminidase release in the the dibutyryl cyclic-AMP differentiated U937 human histiocytic lymphoma cell line in a dose-dependent manner (orange line). N-Acetyl-beta -D-Glucosamin-idase Release elicited by Recombinant Human Complement Component C5a (15 ng/mL) is neutralized (green line) by increasing concen-trations of Goat Anti-Human Complement Component C5a Antigen Affinity-purified Polyclonal Antibody (Catalog # AF2037). The ND₅₀ is typically 0.15-0.75 µg/mL in the presence of cytochalasin-B." alt="Recombinant Human Complement Component C5a (Catalog # 2037-C5) induces N-acetyl- beta -D-glucosaminidase release in the the dibutyryl cyclic-AMP differentiated U937 human histiocytic lymphoma cell line in a dose-dependent manner (orange line). N-Acetyl-beta -D-Glucosamin-idase Release elicited by Recombinant Human Complement Component C5a (15 ng/mL) is neutralized (green line) by increasing concen-trations of Goat Anti-Human Complement Component C5a Antigen Affinity-purified Polyclonal Antibody (Catalog # AF2037). The ND₅₀ is typically 0.15-0.75 µg/mL in the presence of cytochalasin-B." class="big_thumb" />

MAB2037) coated on a Clear Polystyrene Microplate (Catalog # DY990). Mouse Anti-Human Complement Component C5/C5a Monoclonal Antibody (Catalog # MAB20371) was biotinylated and incubated with the protein captured on the plate. Detection of the standard curve was achieved by incubating Streptavidin-HRP (Catalog # DY998) followed by Substrate Solution (Catalog # DY999) and stopping the enzymatic reaction with Stop Solution (Catalog # DY994)." class="big_lightbox"> MAB2037) coated on a Clear Polystyrene Microplate (Catalog # DY990). Mouse Anti-Human Complement Component C5/C5a Monoclonal Antibody (Catalog # MAB20371) was biotinylated and incubated with the protein captured on the plate. Detection of the standard curve was achieved by incubating Streptavidin-HRP (Catalog # DY998) followed by Substrate Solution (Catalog # DY999) and stopping the enzymatic reaction with Stop Solution (Catalog # DY994)." alt="Recombinant Human Complement Component C5/C5a protein was serially diluted 2-fold and captured by Mouse Anti-Human Complement Component C5/C5a Monoclonal Antibody (Catalog # MAB2037) coated on a Clear Polystyrene Microplate (Catalog # DY990). Mouse Anti-Human Complement Component C5/C5a Monoclonal Antibody (Catalog # MAB20371) was biotinylated and incubated with the protein captured on the plate. Detection of the standard curve was achieved by incubating Streptavidin-HRP (Catalog # DY998) followed by Substrate Solution (Catalog # DY999) and stopping the enzymatic reaction with Stop Solution (Catalog # DY994)." class="big_thumb" />

2037-C5) was serially diluted and captured by Mouse Anti-Human Complement Component C5/C5a Monoclonal Antibody (Catalog # MAB2037) coated on a Clear Polystyrene Microplate (Catalog # DY990). Mouse Anti-Human Complement Component C5/C5a Monoclonal Antibody (Catalog # MAB20371) was biotinylated and incubated with the protein captured on the plate. Detection of the standard curve was achieved by incubating Streptavidin-HRP (Catalog # DY998)" class="big_lightbox"> 2037-C5) was serially diluted and captured by Mouse Anti-Human Complement Component C5/C5a Monoclonal Antibody (Catalog # MAB2037) coated on a Clear Polystyrene Microplate (Catalog # DY990). Mouse Anti-Human Complement Component C5/C5a Monoclonal Antibody (Catalog # MAB20371) was biotinylated and incubated with the protein captured on the plate. Detection of the standard curve was achieved by incubating Streptavidin-HRP (Catalog # DY998)" class="big_thumb" />